PLoS Genetics (Jan 2013)

ImmunoChip study implicates antigen presentation to T cells in narcolepsy.

  • Juliette Faraco,
  • Ling Lin,
  • Birgitte Rahbek Kornum,
  • Eimear E Kenny,
  • Gosia Trynka,
  • Mali Einen,
  • Tom J Rico,
  • Peter Lichtner,
  • Yves Dauvilliers,
  • Isabelle Arnulf,
  • Michel Lecendreux,
  • Sirous Javidi,
  • Peter Geisler,
  • Geert Mayer,
  • Fabio Pizza,
  • Francesca Poli,
  • Giuseppe Plazzi,
  • Sebastiaan Overeem,
  • Gert Jan Lammers,
  • David Kemlink,
  • Karel Sonka,
  • Sona Nevsimalova,
  • Guy Rouleau,
  • Alex Desautels,
  • Jacques Montplaisir,
  • Birgit Frauscher,
  • Laura Ehrmann,
  • Birgit Högl,
  • Poul Jennum,
  • Patrice Bourgin,
  • Rosa Peraita-Adrados,
  • Alex Iranzo,
  • Claudio Bassetti,
  • Wei-Min Chen,
  • Patrick Concannon,
  • Susan D Thompson,
  • Vincent Damotte,
  • Bertrand Fontaine,
  • Maxime Breban,
  • Christian Gieger,
  • Norman Klopp,
  • Panos Deloukas,
  • Cisca Wijmenga,
  • Joachim Hallmayer,
  • Suna Onengut-Gumuscu,
  • Stephen S Rich,
  • Juliane Winkelmann,
  • Emmanuel Mignot

DOI
https://doi.org/10.1371/journal.pgen.1003270
Journal volume & issue
Vol. 9, no. 2
p. e1003270

Abstract

Read online

Recent advances in the identification of susceptibility genes and environmental exposures provide broad support for a post-infectious autoimmune basis for narcolepsy/hypocretin (orexin) deficiency. We genotyped loci associated with other autoimmune and inflammatory diseases in 1,886 individuals with hypocretin-deficient narcolepsy and 10,421 controls, all of European ancestry, using a custom genotyping array (ImmunoChip). Three loci located outside the Human Leukocyte Antigen (HLA) region on chromosome 6 were significantly associated with disease risk. In addition to a strong signal in the T cell receptor alpha (TRA@), variants in two additional narcolepsy loci, Cathepsin H (CTSH) and Tumor necrosis factor (ligand) superfamily member 4 (TNFSF4, also called OX40L), attained genome-wide significance. These findings underline the importance of antigen presentation by HLA Class II to T cells in the pathophysiology of this autoimmune disease.